JP2006513238A5 - - Google Patents

Download PDF

Info

Publication number
JP2006513238A5
JP2006513238A5 JP2004565235A JP2004565235A JP2006513238A5 JP 2006513238 A5 JP2006513238 A5 JP 2006513238A5 JP 2004565235 A JP2004565235 A JP 2004565235A JP 2004565235 A JP2004565235 A JP 2004565235A JP 2006513238 A5 JP2006513238 A5 JP 2006513238A5
Authority
JP
Japan
Prior art keywords
iminoethyl
cysteine
ethyl
amino
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004565235A
Other languages
English (en)
Other versions
JP2006513238A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/038792 external-priority patent/WO2004060352A1/en
Publication of JP2006513238A publication Critical patent/JP2006513238A/ja
Publication of JP2006513238A5 publication Critical patent/JP2006513238A5/ja
Pending legal-status Critical Current

Links

Claims (1)

  1. S−[2−[(1−イミノエチル)アミノ]エチル]−2−メチル−L−システインまたはその塩酸塩および少なくとも1種の非‐吸湿性ポリマーを含む固体粒子状組成物であって、前記S−[2−[(1−イミノエチル)アミノ]エチル]−2−メチル−L−システインまたはその塩酸塩および前記少なくとも1種の非‐吸湿性ポリマーが、まず水性液体中に共-分散されて次いで前記液体が除去され、ここで前記組成物が、21〜23℃の温度で40%の相対湿度の条件に24時間曝した場合、約10%以下の質量増加を前記組成物が示すように非‐吸湿性である、前記固体粒子状組成物。
JP2004565235A 2002-12-19 2003-12-05 吸湿性薬物を含む非‐吸湿性製剤 Pending JP2006513238A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43502202P 2002-12-19 2002-12-19
US43514702P 2002-12-19 2002-12-19
US43542202P 2002-12-19 2002-12-19
PCT/US2003/038792 WO2004060352A1 (en) 2002-12-19 2003-12-05 Non-hygroscopic formulation comprising a hydroscopic drug

Publications (2)

Publication Number Publication Date
JP2006513238A JP2006513238A (ja) 2006-04-20
JP2006513238A5 true JP2006513238A5 (ja) 2006-08-10

Family

ID=32719157

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004565235A Pending JP2006513238A (ja) 2002-12-19 2003-12-05 吸湿性薬物を含む非‐吸湿性製剤
JP2004565403A Withdrawn JP2006514052A (ja) 2002-12-19 2003-12-11 吸湿性および/または潮解性の薬剤を含む固体分散剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004565403A Withdrawn JP2006514052A (ja) 2002-12-19 2003-12-11 吸湿性および/または潮解性の薬剤を含む固体分散剤

Country Status (17)

Country Link
US (2) US20050013856A1 (ja)
EP (2) EP1575563B1 (ja)
JP (2) JP2006513238A (ja)
AR (2) AR042511A1 (ja)
AT (1) ATE353633T1 (ja)
AU (2) AU2003298010A1 (ja)
BR (2) BR0317392A (ja)
CA (2) CA2511385A1 (ja)
DE (1) DE60311875T2 (ja)
ES (1) ES2280835T3 (ja)
HN (1) HN2003000417A (ja)
MX (2) MXPA05006802A (ja)
NL (1) NL1025069C2 (ja)
PE (1) PE20040972A1 (ja)
TW (2) TW200423971A (ja)
UY (1) UY28138A1 (ja)
WO (2) WO2004060352A1 (ja)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2262567T3 (es) 2001-03-20 2006-12-01 Schwarz Pharma Ag Nuevo uso de una clase peptidica de compuesto para tratamiento del dolor inflamatorio no neuropatico.
DK1243263T3 (da) * 2001-03-21 2003-03-17 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
CA2511385A1 (en) * 2002-12-19 2004-07-22 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
JP4708795B2 (ja) * 2002-12-20 2011-06-22 ニコノヴァム エービー 物理的および化学的に安定なニコチン−含有粒状物質
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
FR2865133B1 (fr) * 2004-01-19 2008-01-18 Rytek Compositions pour le traitement de pathologies digestives
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EA013591B1 (ru) 2004-04-16 2010-06-30 Шварц Фарма Аг Применение пептидных соединений для профилактики, облегчения и лечения головной боли и болезненных состояний, связанных с или вызванных распространяющейся кортикальной депрессией (csd)
ATE438390T1 (de) * 2004-07-02 2009-08-15 Radi Medical Biodegradable Ab Rauchloses tabakprodukt
EP1781276B1 (en) 2004-08-27 2010-06-23 UCB Pharma GmbH Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
US20090304786A1 (en) * 2005-11-25 2009-12-10 Viswaprasad Varanasi Stable Dosage Forms of an Antidepressant
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
DK2029110T3 (da) * 2006-06-06 2011-12-19 Tibotec Pharm Ltd Fremgangsmåde til fremstilling af sprøjtetørrede formuleringer med TMC125
AR061476A1 (es) * 2006-06-15 2008-08-27 Sanol Arznei Schwarz Gmbh Composicion farmaceutica con efecto anticonvulsivo sinergico
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
JP5484910B2 (ja) * 2006-12-22 2014-05-07 ユーハン・コーポレイション レバプラザン含有の固体分散体及びその製造方法
EP2185472A1 (en) * 2007-08-30 2010-05-19 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
US9358242B2 (en) 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
KR101499533B1 (ko) * 2008-02-15 2015-03-09 주식회사 씨티씨바이오 콜린 알포세레이트 함유 약학 제제
DE102008020701A1 (de) * 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulierung mit reduzierter Hygroskopizität
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
KR101172699B1 (ko) 2011-05-16 2012-08-09 한국프라임제약주식회사 콜린알포세레이트를 함유하는 약학 제제, 및 그의 제조방법
JP2014522893A (ja) 2011-07-07 2014-09-08 ザ ルブリゾル コーポレイション 2ストロークサイクルエンジンのための改善された清浄性を提供する潤滑剤
CN102525992A (zh) * 2012-03-09 2012-07-04 徐奎 L-α-甘油磷酸胆碱薄膜衣片及其制备方法
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
US20150141457A1 (en) * 2012-05-21 2015-05-21 Hetero Research Foundation Elvitegravir solid dispersion
CN105377235A (zh) 2013-07-19 2016-03-02 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
BR112016011111B1 (pt) * 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
GB2525170A (en) * 2014-04-07 2015-10-21 Nokia Technologies Oy Stereo viewing
CN104739776A (zh) * 2015-04-15 2015-07-01 福州乾正药业有限公司 左卡尼汀的固体分散体组合物及其制备方法和药物应用
WO2017013591A1 (en) * 2015-07-22 2017-01-26 Leiutis Pharmaceuticals Pvt Ltd Stabilized liquid formulation of levothyroxine
MX2018011348A (es) * 2016-03-18 2019-07-12 Brian Reid Christopher Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades.
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
JP7319247B2 (ja) * 2018-03-30 2023-08-01 株式会社カネカ 酸化型グルタチオンを含む固体組成物及びその製造方法
CN112316678A (zh) * 2020-10-12 2021-02-05 常州市永勃机械有限公司 一种变电站柜体用驱潮剂制备工艺制备方法
IT202100018578A1 (it) * 2021-07-14 2023-01-14 Indena Spa Dispersione amorfa di maltolo ferrico e relativo processo di preparazione

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JPH02218621A (ja) * 1989-02-20 1990-08-31 Nippon Chemiphar Co Ltd 徐放性製剤
US5582837A (en) * 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5688510A (en) * 1993-11-18 1997-11-18 Nippon Shinyaku Co. Ltd. Process for producing stable medicinal composition, and pharmaceutical preparation
JPH08157392A (ja) * 1994-12-01 1996-06-18 Kanegafuchi Chem Ind Co Ltd 放出制御型製剤
GB9607955D0 (en) * 1996-04-17 1996-06-19 Tillotts Pharma Ag Hydrophobic carbomer salt compositions
JPH10182448A (ja) * 1996-12-24 1998-07-07 Zensei Yakuhin Kogyo Kk 圧縮製剤用組成物の製造方法
MA25590A1 (fr) * 1998-09-14 2002-12-31 Inhale Therapeutic Syst Agent actif de delivraison de poudre seche
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
ATE295832T1 (de) * 2000-03-24 2005-06-15 Pharmacia Corp Amidino-verbindung sowie salze davon verwendbar als hemmstoffe der stickstoffmonoxid-synthase
US20020143058A1 (en) * 2001-01-24 2002-10-03 Taro Pharmaceutical Inductries Ltd. Process for preparing non-hygroscopic sodium valproate composition
CA2511385A1 (en) * 2002-12-19 2004-07-22 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug

Similar Documents

Publication Publication Date Title
JP2006513238A5 (ja)
JP2003213038A5 (ja)
HUP0303103A2 (hu) Kondenzált pirrolokarbazolok, ezeket tartalmazó gyógyszerkészítmények és a vegyületek alkalmazása
RU2302408C3 (ru) Гидроксаматные производные, применимые в качестве ингибиторов дезацетилазы
JP2007519619A5 (ja)
KR920021578A (ko) 포스프노/비아릴 치환된 디펩티드 유도체
JP2005532678A5 (ja)
NO20013674D0 (no) Acetyleniske <alfa>-aminosyre-baserte sulfonamid- hydroksamsyre TACE-inhibitorer
KR930016389A (ko) No 신타제 및 시클로옥시게나제의 이중 억제제, 이들의 제조방법 및 이들을 함유하는 치료 조성물
JP2014012726A5 (ja)
JP2009501177A5 (ja)
JP2009501178A5 (ja)
JP2006276598A5 (ja)
JP2007504212A5 (ja)
JP2008512570A5 (ja)
JP2003510285A5 (ja)
TR200102811T2 (tr) Oral uygulama için, tolpersiyon içeren farmasötik preparat.
CA2425655A1 (en) Drugs for diabetes
NO20034236L (no) Ny fremgangsmate for den industrielle syntese av tetraestere av 5-[bis(karboksymetyl)amino]-3-karboksymetyl-4-cyano-2-tiofenkarboksylsyre, og anvendelse i syntesen av bivalente salter av ranelinsyre og deres hydrater
JP2004532624A5 (ja)
JP2007505905A5 (ja)
JP2010512326A5 (ja)
JP2004523545A5 (ja)
JP2006517932A5 (ja)
JP2005522492A5 (ja)